The Indian Government, on Monday, launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG). The drug was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a lab of India’s Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL), in the southern city Hyderabad, is used to treat COVID-19 patients. The first batch of the drug was handed over by the Federal Defence Minister, Rajnath Singh, to the Federal Health Minister, Harsh Vardhan, in the capital New Delhi. The 2-DG drug was recently given approval for emergency use by the Drugs Controller General of India. India has been hit by a devastating second wave of COVID-19 infections. The health ministry earlier said 281,386 new cases and 4,106 related deaths were registered in the past 24 hours across the country. (Xinhua/NAN)  The Indian Government, on Monday, launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG). The drug was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a lab of India’s Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL), in the southern city Hyderabad, is used to treat COVID-19 patients. The first batch of the drug was handed over by the Federal Defence Minister, Rajnath Singh, to the Federal Health Minister, Harsh Vardhan, in the capital New Delhi. The 2-DG drug was recently given approval for emergency use by the Drugs Controller General of India. India has been hit by a devastating second wave of COVID-19 infections. The health ministry earlier said 281,386 new cases and 4,106 related deaths were registered in the past 24 hours across the country. (Xinhua/NAN) Share this:WhatsAppFacebookTwitterTelegramMoreLinkedInTumblrSkypeRedditPinterestPocket Share this:WhatsAppFacebookTwitterTelegramMoreLinkedInTumblrSkypeRedditPinterestPocket WhatsAppFacebookTwitterTelegramMoreLinkedInTumblrSkypeRedditPinterestPocket LinkedInTumblrSkypeRedditPinterestPocket LinkedInTumblrSkypeRedditPinterestPocket Like this:Like Loading... Like Loading...  	Related No adverse reaction observed in COVID-19 vaccination - NPHDCABy Abujah Racheal The National Primary Health Care Development Agency (NPHCDA) has said that since the country commenced its COVID-19 vaccination, no Nigerian has observed any adverse reaction, noting that all side effects reported by those who have taken the jab have been mild. Dr. Faisal Shuaib, Executive Director, NPHCDA,…March 12, 2021In "Health"FG launches strategy to introduce COVID-19 vaccine The Federal Government has launched a strategy for the introduction of the COVID-19 vaccine in a phased and equitable manner.March 1, 2021In "General News"NAFDAC ready to work with scientists on COVID-19 drugs, vaccines -DGBy Aderogba George The National Agency for Food and Drug Administration and Control (NAFDAC) will collaborate with indigenous scientists in the development of drugs or vaccines against the coronavirus disease (COVID-19) in the country. Prof. Mojisola Adeyeye, NAFDAC Director-General, said the agency’s interventions would allow for documentation of such initiatives…June 23, 2020In "Features" No adverse reaction observed in COVID-19 vaccination - NPHDCABy Abujah Racheal The National Primary Health Care Development Agency (NPHCDA) has said that since the country commenced its COVID-19 vaccination, no Nigerian has observed any adverse reaction, noting that all side effects reported by those who have taken the jab have been mild. Dr. Faisal Shuaib, Executive Director, NPHCDA,…March 12, 2021In "Health"FG launches strategy to introduce COVID-19 vaccine The Federal Government has launched a strategy for the introduction of the COVID-19 vaccine in a phased and equitable manner.March 1, 2021In "General News"NAFDAC ready to work with scientists on COVID-19 drugs, vaccines -DGBy Aderogba George The National Agency for Food and Drug Administration and Control (NAFDAC) will collaborate with indigenous scientists in the development of drugs or vaccines against the coronavirus disease (COVID-19) in the country. Prof. Mojisola Adeyeye, NAFDAC Director-General, said the agency’s interventions would allow for documentation of such initiatives…June 23, 2020In "Features" No adverse reaction observed in COVID-19 vaccination - NPHDCABy Abujah Racheal The National Primary Health Care Development Agency (NPHCDA) has said that since the country commenced its COVID-19 vaccination, no Nigerian has observed any adverse reaction, noting that all side effects reported by those who have taken the jab have been mild. Dr. Faisal Shuaib, Executive Director, NPHCDA,…March 12, 2021In "Health" FG launches strategy to introduce COVID-19 vaccine The Federal Government has launched a strategy for the introduction of the COVID-19 vaccine in a phased and equitable manner.March 1, 2021In "General News" NAFDAC ready to work with scientists on COVID-19 drugs, vaccines -DGBy Aderogba George The National Agency for Food and Drug Administration and Control (NAFDAC) will collaborate with indigenous scientists in the development of drugs or vaccines against the coronavirus disease (COVID-19) in the country. Prof. Mojisola Adeyeye, NAFDAC Director-General, said the agency’s interventions would allow for documentation of such initiatives…June 23, 2020In "Features"